Actually GM-CSF-deficient mice are resistant to EAE [69, 133] and GM-CSF production by Th17 cells is crucial for their capacity to induce EAE [70, 134], likely supporting recruitment of peripheral macrophages, inflammatory monocytes, and expansion of T cells [69, 135, 136]. Another cytokine produced by Th17 cells is usually IL-21, whose administration before induction of EAE Nicotinuric acid enhances the inflammatory influx into the CNS as well as the severity of the disease [137], likely due to the role of IL-21 in the induction and expansion of Th17 cells [88, 90, 138]. mediate their particular responses. The identification in the features Nicotinuric acid endowing Th17 cells with substantial pathogenicity in MS is of particular interest, and discoveries in Th17 cell biology and function could lead to the design of new strategies targeted at modulating the immune response in MS. Here, we will discuss recent improvements in this field, with particular focus on the mechanisms conferring pathogenicity in MS and their potential modulation. == 1 . Introduction == Differentiation of naive CD4+T cells into T helper (Th) cells with diverse effector functions is crucial to get the organization of an adaptive immune response. Until recently, only two major cell subsets, Th1 and Th2, were used to describe the different adaptive defense responses established to eliminate pathogens [13]. Th1 cells stimulate cell mediated inflammatory responses against intracellular bacteria [47], whilst Th2 cells activate a protective response against helminth infection [8]. However , persistent or uncontrolled effector T cell responses are associated with pathological states and tissue damage: an excessive Th2 cell response is responsible for atopic diseases, such as asthma [9], and an irregular Th1 cell response can mediate chronic inflammation and is involved in a number Nicotinuric acid of autoimmune illnesses [10, 11]. In 1998 the finding of CD4+T cells creating IL-17 [12] unveiled the presence of another subset of Th cells, the Th17 subset, distinct coming from Th1 and Th2 [13, 14], and its finding has helped the understanding of immune responses unexplained by the Th1/Th2 paradigm, such as the response against fungi likeCandida albicans[15] and extracellular bacteria such asPseudomonas aeruginosa[16], Klebsiella pneumoniae[17], Streptococcus pneumoniae[18], andStaphylococcus aureus[19], and the development of autoimmune disorders, such as multiple sclerosis (MS), Crohn’s disease, psoriasis, and rheumatoid arthritis. The pathogenic part of Th17 cells in autoimmune illnesses is supported by both individual studies and experiments performed in dog models. Indeed, IL-17A is highly expressed in the central nervous system (CNS) lesions and in the blood and cerebrospinal fluid (CSF) of patients with MS [2024], in the colonic mucosa of individuals with ulcerative colitis or Crohn’s disease [25, 26], in the psoriatic skin [27, 28], and in the synovial tissues coming from rheumatoid arthritis individuals [29]. Studies in murine versions such as experimental autoimmune encephalomyelitis (EAE) [30], trinitrobenzene sulfuric acid- (TNBS-) induced colitis [31], and antigen or collagen-induced joint disease [32] expose that the IL-17 pathway plays a pathogenic role in autoimmune disorders. Finally, the concept that Th17 cells are responsible for traveling autoimmune inflammation was finally established when EAE, the mouse model of MS, was shown to be induced by passive transfer of IL-17-producing myelin reactive CD4 T cells [33]. In this review we discuss our current understanding of the Nicotinuric acid Th17 lineage, focusing on the factors regulating their differentiation, their common features, their particular pathological functions in MS, and the potential modulation of their response to get therapeutic techniques. == 2 . Cytokine Production by Th17 Cells == IL-17 may be the cytokine created specifically by Th17 cells. IL-17A (commonly referred to as IL-17) is part of a cytokine family including IL-17B, IL-17C, IL-17D, IL-17E (also referred to as IL-25), and IL-17F [34]. Almost all members of the family show some conserved regions: IL-17A and IL-17F (the only cytokines of this family created by Th17 cells) are the most similar to a 55% homology and exert comparable functions [35]; IL-25 has the series with cheapest similarity to IL-17A (only 16%) and plays unique roles in Nicotinuric acid immunity, generally regulating the Th2 response against helminthic parasites and allergic inflammation [3638]. IL-17B, IL-17C, and IL-17D have been shown to induce Rabbit Polyclonal to ASC the production of proinflammatory cytokines, but their biological function is largely unfamiliar [3942]. Recent studies by three different organizations have outlined the function of IL-17C in mucosal immunity and in autoimmune responses [4345]. Within the IL-17 family of cytokines, the biological function and regulation of IL-17A and IL-17F are the best recognized. Both are created by Th17 cells and can also act as heterodimers [46]. The effective signalling of IL-17A and IL-17F requires the IL-17 receptor (IL-17R), a heteromeric complex comprising IL-17RA and IL-17RC [47]. Although both receptors are extensively expressed in different tissues and cell types [4850] functional studies possess focused generally on epithelial cells. Both IL-17A and IL-17F stimulate epithelial cells to produce granulopoietic colony revitalizing factor (G-CSF), stem cell factors that regulate granulopoiesis, and CXC chemokines (CXCL1, CXCL2, CXCL5, and CXCL8) responsible for neutrophil recruitment [5153]. IL-17A increases the manifestation of mucins such as MUC5AC and MUC5B in main human bronchial epithelial cellsin vitro[54]. In addition , IL-17A also induces the expression of human beta defensin-2 [55] and CCL20 in lung epithelial cells [56]. This cooperative induction of neutrophil recruitment and antimicrobial-peptide production enhances epithelial-barrier honesty and may be critical for mucosal host defense against extracellular bacteria and fungi. Moreover, several studies have recorded the part of IL-17 in regulating antibody generation by.